We use cookies for a better user experience. Read our Privacy Policy

I Agree

Hurthle Cell Carcinoma Treatment Market

Hurthle Cell Carcinoma Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Hurthle Cell Carcinoma Treatment Market: Introduction

  • Hurthle cell carcinoma (HCC) is rare type of cancer, which affects the thyroid gland. HCC cancer is also known as oxyphilic cell carcinoma. Thyroid gland tumors are relatively very rare, which represents that HCC is one of the several types of cancers, which is known to affect the thyroid gland. The thyroid gland is a butterfly shaped gland seen at the base of the human neck. Thyroid gland is important as it secretes the thyroid hormone, which regulates the body’s metabolism.  
  • HCC usually is a widely invasive tumor as compared to other thyroid tumors. It is also associated with a high rate of distant metastases. HCC cancer accounts for approximately about 4%–10% of differentiated thyroid cancers.
  • Researchers and scientists believe that the behavior of the HCC cancer is the same as that of follicular cell cancers, but slightly less aggressive. The Centers for Disease Control and Prevention research findings suggests that HCC tumors are most common between the age of 50 years and 60 years, but in a few exceptional cases, they have been reported in people aged between 20 years and 85 years. Research findings also suggest that these tumors are also common among women as compared to men.
  • Hurthle cell cancer usually spreads via invasion in to the blood vessels. In a few cases, HCC cancers, which are small and do not show signs of invasion into lymph nodes or blood vessels, are very unlikely to spread.

Key Drivers of Global Hurthle Cell Carcinoma Treatment Market

  • Global hurthle cell carcinoma treatment market is expected to grow rapidly in the near future. For instance, given the low incidence rate, several research institutions and pharma companies are focusing on examining clinical characteristics and finding out optimal treatment methods. In the case of HCC, disease-free interval, cancer related survival rates, prognostic factors as well as literature are precisely scarce. These scenarios are expected to drive the global hurthle cell carcinoma treatment market, as research organizations and pharma companies are gaining positive insights, which may help in the treatment of the disease.
  • Additionally, several technological developments has led to the increase in research and development activities of HCC treatment options, which has offered various advantages to manufacturers. This is expected to drive the global market. For instance, HCC treatment particularly depends on the exact stage of the cancer, such as size of the cancer, location, overall health of patient, etc.

North America to Hold Major Share of Global Hurthle Cell Carcinoma Treatment Market

  • Due to technological advancements and high adoption rate, North America dominates the hurthle cell carcinoma treatment market, followed by Europe and Asia Pacific
  • Asia Pacific is expected to be the most lucrative market in the near future due to developing medical infrastructure, medical tourism, rise in acceptance of technologically advanced surgical procedures, and increase in government initiatives

Key Players Operating in Global Market

The global hurthle cell carcinoma treatment market is highly consolidated with major manufacturers adopting various research strategies to gain market share. Only a few companies have their presence in the market, while some of them have their products in the pipeline.

Some of the key players operating in the global hurthle cell carcinoma treatment market are:

  • Smith & Nephew plc
  • Pfizer, Inc.
  • EISAI Inc.
  • Sanofi-Aventis
  • Sun Pharmaceuticals
  • Cadila Healthcare Ltd

Global Hurthle Cell Carcinoma Treatment Market: Research Scope

Global Hurthle Cell Carcinoma Treatment Market, by Treatment

  • General Surgery
  • Total Thyroidectomy
  • Robotic Surgery
  • Radioactive Iodine (RAI)
  • Others

Global Hurthle Cell Carcinoma Treatment Market, by End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Others

Global Hurthle Cell Carcinoma Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Rest of Middle East & Africa
Hurthle Cell Carcinoma Treatment Market

Interested in this report?
Get a FREE Brochure now!

Request Brochure

*Get Brochure (PDF) sent to your email within minutes

N/A

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

211

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved